Children's Brain Tumor Network Names Dr. John Prensner as New Scientific Co-Chair
PHILADELPHIA, Nov. 5, 2025 /PRNewswire/ -- The Children's Brain Tumor Network (CBTN) announced the appointment of John Prensner, MD, PhD, as its new Scientific Co-Chair. A pediatric neuro-oncologist and physician-scientist at the Chad Carr Pediatric Brain Tumor Center at the University of Michigan, Dr. Prensner combines clinical care with leading-edge genomics and RNA biology research to advance discoveries for children with high-risk brain tumors.
費城，2025年11月5日/PRNewswire/ -- 兒童腦腫瘤網絡（CBTN）宣佈任命 John Prensner, 醫學博士，哲學博士爲新的科學聯合主席。作爲一名兒科神經腫瘤學家和醫師科學家，在Chad Carr Pediatric Brain Tumor Center的{{|姓名_0|}}博士結合臨床護理與前沿基因組學及RNA生物學研究，以推動高風險腦腫瘤兒童的發現。 密歇根大學
As Co-Chair, Dr. Prensner will work to guide CBTN's scientific strategy, strengthen multi-institutional collaborations, and champion open data initiatives that accelerate translation from discovery to treatment.
作爲聯合主席，Prensner博士將致力於指導CBTN的科學戰略，加強多機構合作，並倡導加速從發現到治療的開放數據計劃。
"CBTN demonstrates how open science can transform the pace of pediatric cancer research," said Dr. Prensner. "By uniting data, tools, and expertise across institutions, we're building the foundation for tomorrow's breakthroughs in care."
Prensner博士表示：「CBTN展示了開放科學如何能夠改變兒科癌症研究的步伐。通過聯合各機構的數據、工具和專業知識，我們正在爲未來的醫療突破奠定基礎。」
The Prensner Lab studies the non-coding genome—the 98% of DNA outside known genes—and how RNA translation and the dark proteome drive childhood brain tumors such as medulloblastoma, ATRT, and DIPG/DMG. His research seeks to uncover hidden cancer driver genes and identify RNA-based therapeutic opportunities.
Prensner實驗室研究非編碼基因組——已知基因之外98%的DNA——以及RNA翻譯和暗蛋白質組如何驅動兒童腦腫瘤，如髓母細胞瘤、非典型畸胎樣橫紋肌樣瘤（ATRT）和瀰漫性內生型腦橋膠質瘤（DIPG/DMG）。他的研究旨在揭示隱藏的癌症驅動基因並識別基於RNA的治療機會。
A leader in global collaboration, Dr. Prensner co-chairs the international TransCODE Consortium on the non-canonical proteome and works with CBTN and the NCI Clinical Proteomic Tumor Analysis Consortium (CPTAC) to standardize data and accelerate pediatric glioma research. He also serves as Co-PI/Co-Investigator on multiple early-phase clinical studies.
作爲一名全球協作的領導者，Prensner博士共同主持國際TransCODE聯盟關於非規範蛋白質組的研究，並與CBTN和NCI臨床蛋白質組腫瘤分析聯盟（CPTAC）合作，標準化數據並加速小兒膠質瘤研究。他還擔任多個早期臨床研究的聯合首席研究員（Co-PI/Co-Investigator）。
"Dr. John Prensner is a collaborative physician-scientist whose leadership unites leading-edge RNA biology with compassionate clinical care to accelerate therapies for children with brain tumors," said Adam Resnick, PhD, Executive Chair, CBTN. "His work exemplifies how shared data and discovery can lead to meaningful advances for children and families."
John Prensner博士是一位協作的醫師科學家，其領導力將前沿的RNA生物學與富有同情心的臨床護理相結合，從而加速兒童腦腫瘤的治療進程，" 說道。 Adam Resnick，博士，CBTN執行主席。「他的工作展示了共享數據和發現如何能夠爲兒童和家庭帶來有意義的進展。」
About Children's Brain Tumor Network (CBTN)
The Children's Brain Tumor Network (CBTN) is a global research initiative dedicated to transforming the landscape of pediatric brain tumor research and care. With 35 member institutions, CBTN has collected more than 110,000 biospecimens and enrolled over 8,000 participants—creating the world's largest pediatric brain tumor data resource. By enabling real-time data sharing and interdisciplinary collaboration, CBTN empowers researchers to drive innovation and deliver answers faster to the children and families who need them most. Learn more at cbtn.org.
關於兒童腦腫瘤網絡（CBTN）
兒童腦腫瘤網絡（CBTN）是一個全球研究倡議，致力於改變兒科腦腫瘤研究和護理的格局。擁有35個成員機構，CBTN收集了超過11萬份生物樣本，並登記了8000多名參與者——創建了世界上最大的兒科腦腫瘤數據資源。通過實現實時數據共享和跨學科合作，CBTN幫助研究人員推動創新並更快地爲需要的兒童和家庭提供答案。了解更多信息，請訪問 cbtn.org.
Contact:
聯繫：
Emily Reed
Children's Brain Tumor Network
[email protected]
Emily Reed
兒童腦腫瘤網絡
[email protected]
SOURCE Children's Brain Tumor Network
來源：Children's Brain Tumor Network
21%
21%
譯文內容由第三人軟體翻譯。